Mintz advised the underwriter in connection with a $75 million underwritten offering by MoonLake Immunotherapeutics of 7,142,857 Class A ordinary shares at an offering price of $10.50 per share. The aggregate gross proceeds to MoonLake Immunotherapeutics from this offering were approximately $75 million before deducting underwriting discounts and commissions and other offering expenses.

Leerink Partners acted as sole book-running manager for the offering.

The Mintz capital markets team included William C. Hicks, John Rudy, Nishant Dharia, Allyson Wilkinson, Gianna Nappi, Jocelyn Sun, and Emily Dougherty. Joanne Hawana provided regulatory advice, and Terri Shieh-Newton and Evelyne Guillouet provided intellectual property advice. Members of the Mintz team are based in the Boston, New York, Washington, DC, San Diego, and San Francisco offices.